Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : email@example.com
CYNK-001 (taniraleucel) consists of allogeneic CD56+/CD3- natural killer cells expanded from CD34-positive placental stem cells, which may induce cytotoxicity against tumor cells and potentially demonstrates anti-tumor activity (Neuro-Oncology, Vol. 21, Issue Suppl_6, Nov. 2019, Page vi85, EXTH-16).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|